» Articles » PMID: 32561438

Coronavirus Disease 2019 and Smoking: How and Why We Implemented a Tobacco Treatment Campaign

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2020 Jun 21
PMID 32561438
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Smoking is associated with one of five deaths in the United States. Multimodality tobacco treatment increases rates of successful cessation by at least 20%. The coronavirus disease 2019 pandemic has put a halt to many inpatient and outpatient medical visits that have been deemed nonessential, including tobacco treatment. The transition to telehealth has been wrought with challenges. Although data on the association between coronavirus disease 2019 and tobacco products are mixed, the overall health consequences of tobacco point towards increased risk of morbidity and death that is associated with the virus. This leaves smoking as one of the few readily modifiable risk factors in an environment understandably not set up to prioritize cessation. A military health facility on Fort Eustis in Virginia runs a successful tobacco treatment program and adapted it to pandemic times. This article describes the process and lessons learned from this initiative. The model is applicable and scalable to government and civilian health centers as health care adapts to a new normal.

Citing Articles

Influence of smoking history on the evolution of hospitalized in COVID-19 positive patients: Results from the SEMI-COVID-19 registry.

Navas Alcantara M, Montero Rivas L, Guisado Espartero M, Rubio-Rivas M, Ayuso Garcia B, Moreno Martinez F Med Clin (Engl Ed). 2022; 159(5):214-223.

PMID: 35935808 PMC: 9339973. DOI: 10.1016/j.medcle.2022.07.010.


System-Level Quality Improvement Initiatives for Tobacco Use in a Safety-Net Health System During the COVID-19 Pandemic.

Chung K, Rafferty H, Suen L, Vijayaraghavan M J Prim Care Community Health. 2022; 13:21501319221107984.

PMID: 35748431 PMC: 9234926. DOI: 10.1177/21501319221107984.


The Effect of COVID-19 on Smoking and Vaping Rates.

Lang A Ann Am Thorac Soc. 2022; 19(8):1440-1441.

PMID: 35533309 PMC: 9353957. DOI: 10.1513/AnnalsATS.202202-119LE.


Cross-Sectional Survey of Smoking Patterns During the COVID-19 Pandemic in a Tobacco Cessation and Lung Cancer Screening Program.

Mejia M, Zoorob R, Levine R, Huang X, Hennekens C Ochsner J. 2022; 22(1):48-60.

PMID: 35355638 PMC: 8929218. DOI: 10.31486/toj.21.0082.


Impact of the COVID-19 pandemic on smoking behavior and beliefs among the American University of Beirut community.

Al Ghadban Y, Zgheib N, Romani M, Akl I, Nasr R Tob Prev Cessat. 2022; 8:02.

PMID: 35118214 PMC: 8785139. DOI: 10.18332/tpc/144499.


References
1.
Ryder M, Saghizadeh M, Ding Y, Nguyen N, Soskolne A . Effects of tobacco smoke on the secretion of interleukin-1beta, tumor necrosis factor-alpha, and transforming growth factor-beta from peripheral blood mononuclear cells. Oral Microbiol Immunol. 2002; 17(6):331-6. DOI: 10.1034/j.1399-302x.2002.170601.x. View

2.
Mills E, Debets-Ossenkopp Y, Verbrugh H, Verhoef J . Initiation of the respiratory burst of human neutrophils by influenza virus. Infect Immun. 1981; 32(3):1200-5. PMC: 351579. DOI: 10.1128/iai.32.3.1200-1205.1981. View

3.
Cheng Y, Liu Z, Yao F, Zeng W, Zheng D, Dong Y . Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. PLoS Med. 2013; 10(9):e1001515. PMC: 3775725. DOI: 10.1371/journal.pmed.1001515. View

4.
Alroumi F, Abdul Azim A, Kergo R, Lei Y, Dargin J . The impact of smoking on patient outcomes in severe sepsis and septic shock. J Intensive Care. 2018; 6:42. PMC: 6064183. DOI: 10.1186/s40560-018-0312-x. View

5.
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y . Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71(15):762-768. PMC: 7108125. DOI: 10.1093/cid/ciaa248. View